Skip to main content
. Author manuscript; available in PMC: 2021 Aug 1.
Published in final edited form as: Exp Clin Psychopharmacol. 2020 Mar 5;28(4):426–437. doi: 10.1037/pha0000357

Table 3.

Standardized parameter estimates (standard errors) from the traditional and nested cross-lagged panel models examining cannabis use

Model 1 Model 2 Model 3 Model 4
Autoregressive

Cannabis Use
 Bl → 6mo 0.75 (0.03)*** 0.77 (0.03)*** 0.75 (0.03)*** 0.77 (0.03)***
 6mo → 12mo 0.82 (0.02)*** 0.82 (0.02)*** 0.82 (0.02)*** 0.82 (0.02)***
Depression Symptoms
 Bl → 6mo 0.64 (0.04)*** 0.64 (0.04)*** 0.66 (0.03)*** 0.65 (0.03)***
 6mo → 12mo 0.60 (0.04)*** 0.60 (0.04)*** 0.63 (0.04)*** 0.63 (0.04)***

Cross-lagged

Cannabis Use → Depression Symptoms
 Bl → 6mo 0.04 (0.05) 0.04 (0.05)
 6mo → 12mo 0.11 (0.05)** 0.11 (0.05)**
Depression Symptoms → Cannabis Use
 Bl → 6mo 0.06 (0.04) 0.06 (0.04)
 6mo → 12mo 0.01 (0.03) 0.01 (0.03)

Covariance

Cannabis Use/ Depression Symptoms
 Bl 0.30 (0.05)*** 0.30 (0.05)*** 0.30 (0.05)*** 0.30 (0.05)***
 6mo 0.10 (0.06) 0.09 (0.06) 0.09 (0.06) 0.09 (0.06)
 12mo 0.03 (0.06) 0.03 (0.06) 0.03 (0.06) 0.03 (0.06)

Note. Model 1: Bidirectional associations from depression symptoms to cannabis use vs. cannabis use to depression symptoms; Model 2: cannabis use to depression symptoms; Model 3: depression symptoms to cannabis use; Model 4: no cross-lagged parameters modeled. Assessments: Bl=baseline; 6mo=6 months post-baseline; 12mo=12 months post-baseline.